David Moatazedi
Chief Executive Officer at EVOLUS, INC.
Net worth: 10 M $ as of 2024-03-30
Profile
David Moatazedi is currently the President, Chief Executive Officer & Director at Evolus, Inc. and an Independent Director at Biomerica, Inc. He previously served as an Independent Director at Obalon Therapeutics, Inc., Senior Vice President at Allergan, Inc., and District Manager at.
Novartis Pharmaceuticals Corp.
Moatazedi holds an undergraduate degree from The California State University and an MBA from Pepperdine University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
EVOLUS, INC.
1.12% | 2024-03-26 | 689,614 ( 1.12% ) | 10 M $ | 2024-03-30 |
David Moatazedi active positions
Companies | Position | Start |
---|---|---|
EVOLUS, INC. | Chief Executive Officer | 2018-05-05 |
BIOMERICA, INC. | Director/Board Member | 2022-12-06 |
Former positions of David Moatazedi
Companies | Position | End |
---|---|---|
RESHAPE LIFESCIENCES INC. | Director/Board Member | 2020-06-29 |
ALLERGAN, INC. | Corporate Officer/Principal | 2018-04-30 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2005-02-28 |
Training of David Moatazedi
The California State University | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOMERICA, INC. | Health Technology |
Private companies | 4 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Evolus, Inc. | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- David Moatazedi